Latest Clinical trial Stories
Company CEO to present on October 28, 2014 JERUSALEM, October 24, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc.
Cite Barriers to Genetic Testing, Access to New Therapies as Thwarting Progress WASHINGTON, Oct.
BARCELONA, Spain, October 23, 2014 /PRNewswire/ -- Clients benefit from complete access, visibility, and control throughout the
NORWALK, Conn., Oct.
Results indicate Zalviso controlled moderate-to-severe acute pain following abdominal surgery better than placebo, with similar side effect profile REDWOOD CITY, Calif., Oct.
-- Telotristat etiprate, a Phase 3 compound for the treatment of carcinoid syndrome PARIS and THE WOODLANDS, Texas, Oct.
Quorum Review IRB, the industry leader in central IRB services, announces Director of Regulatory Affairs and General Counsel Linda Coleman, JD, CIP, CHC, CHRC, as a presenter at MAGI’s 2014
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.